clindamycin
A carbohydrate-containing antibiotic that is the semisynthetic derivative of lincomycin, a natural antibiotic.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
lincosamide antibioticARO:0000017
- carbohydrate-containing antibiotic
CHEBI:23007 -
CHEBI:35275 -
CHEBI:36683 -
CHEBI:46770 -
CHEBI:72588 - lincosamide antibiotic
ARO:0000017
Chemical structure
| Charge | |
|---|---|
| Source | ChEBI |
| InChIKey | KDLRVYVGXIQJDK-AWPVFWJPSA-N |
[H][C@]1([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O
InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1
Also called
- methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-α-D-galacto-octopyranoside
- 7(S)-chloro-7-deoxylincomycin
- 7-CDL
- 7-deoxy-7(S)-chlorolincomycin
- Cleocin (TN)
- Clindamycin
- Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
- CLI
- Chlolincocin
- Chlorlincocin
- Cleocin
- Clindamicina
- Clindamycine
- Clindamycinum
- Clinimycin
- Sobelin
Cross-references
- clindamycin
ARO:0000066 - cas:18323-44-9
- hmdb:HMDB0015321
- kegg.compound:C06914
- pdb-ccd:CLY
- reaxys:5624049
- chembl:CHEMBL1753
- pubchem.compound:446598
Drug registries
Patents and articles
Activity roles
- antimicrobial agent
CHEBI:33281
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:0000066 |
clindamycin | antibioticmech:aro-11403b4da5 |
2026-08-30 |
| CHEBI | CHEBI:3745 |
clindamycin | antibioticmech:chebi-9aa5cc907d |
2026-08-30 |
Molecular targets
antibiotic sensitive peptidyl transferase (23S rRNA) NUCLEIC_ACID DIRECT_BINDING_TARGET
Activity spectrum
| Organism | Activity | MIC | Disk diffusion | Assay | Strain | Sample/genome | Evidence |
|---|---|---|---|---|---|---|---|
| Staphylococcus aureus NCBITaxon:1280 | — | 0.5 mg/L | — | Broth microdilution clindamycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 0701 |
BioSample SAMN11953851 |
EvidencePage data (JSON.gz) |
| Staphylococcus haemolyticus NCBITaxon:1283 | — | 2.0 mg/L | — | Broth microdilution clindamycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 0729 |
BioSample SAMN11953879 |
EvidencePage data (JSON.gz) |
| Staphylococcus haemolyticus NCBITaxon:1283 | — | 2.0 mg/L | — | Broth microdilution clindamycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 0730 |
BioSample SAMN11953880 |
EvidencePage data (JSON.gz) |
Resistance mechanisms
ANTIBIOTIC_TARGET_ALTERATION 42
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Clostridioides difficile 23S rRNA with mutation conferring resistance to erythromycin and clindamycin | ARO:3004654 | — | ||
| Erm(33) | ARO:3000599 | — | ||
| Erm(34) | ARO:3000600 | — | ||
| Erm(35) | ARO:3000604 | — | ||
| Erm(36) | ARO:3000605 | — | ||
| Erm(37) | ARO:3000392 | — | ||
| Erm(38) | ARO:3000601 | — | ||
| Erm(39) | ARO:3000602 | — | ||
| Erm(41) | ARO:3000603 | — | ||
| Erm(42) | ARO:3003106 | — | ||
| Erm(43) | ARO:3003205 | — | ||
| Erm(44)v | ARO:3003971 | — | ||
| Erm(47) | ARO:3003908 | — | ||
| Erm(48) | ARO:3004094 | — | ||
| Erm(49) | ARO:3004626 | — | ||
| Erm(50) | ARO:3007032 | — | ||
| Erm(51) | ARO:3007033 | — | ||
| Erm(52) | ARO:3007041 | — | ||
| ErmA | ARO:3000347 | — | ||
| ErmB | ARO:3000375 | — | ||
| ErmC | ARO:3000250 | — | ||
| ErmD | ARO:3000495 | — | ||
| ErmE | ARO:3000326 | — | ||
| ErmF | ARO:3000498 | — | ||
| ErmG | ARO:3000522 | — | ||
| ErmN | ARO:3000592 | — | ||
| ErmQ | ARO:3000593 | — | ||
| ErmR | ARO:3000594 | — | ||
| ErmT | ARO:3000595 | — | ||
| ErmX | ARO:3000596 | — | ||
| Escherichia coli 23S rRNA with mutation conferring resistance to clindamycin | ARO:3004149 | — | ||
| LlmA 23S ribosomal RNA methyltransferase | ARO:3003982 | — | ||
| cfr(B) | ARO:3004649 | — | ||
| cfrA | ARO:3003441 | — | ||
| cipA | ARO:3003907 | — | ||
| clbA | ARO:3002814 | — | ||
| clbB | ARO:3002815 | — | ||
| clbC | ARO:3002816 | — | ||
| clcD | ARO:3004599 | — | ||
| erm(40) | ARO:3004606 | — | ||
| erm(45) | ARO:3004595 | — | ||
| erm(56) | ARO:3007654 | — |
ANTIBIOTIC_TARGET_PROTECTION 16
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Clostridioides difficile cplR | ARO:3007637 | — | ||
| Clostridium perfringes cplR | ARO:3007644 | — | ||
| Clostridium sporogenes cplR | ARO:3007645 | — | ||
| lmrC | ARO:3002881 | — | ||
| lsaA | ARO:3000300 | — | ||
| lsaB | ARO:3003111 | — | ||
| lsaC | ARO:3003112 | — | ||
| lsaD | ARO:3005121 | — | ||
| salA | ARO:3003749 | — | ||
| salB | ARO:3007026 | — | ||
| salC | ARO:3007027 | — | ||
| vga(E) Staphylococcus cohnii | ARO:3004715 | — | ||
| vgaA | ARO:3002829 | — | ||
| vgaALC | ARO:3002830 | — | ||
| vgaC | ARO:3002831 | — | ||
| vgaE | ARO:3002833 | — |
ANTIBIOTIC_INACTIVATION 4
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| LnuH | ARO:3004600 | — | ||
| lnuB | ARO:3002836 | — | ||
| lnuD | ARO:3002838 | — | ||
| lnuF | ARO:3002839 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
CURATED_RESISTANT_TAXA
Added three stable-URL CDC/FDA AR Isolate Bank Panel 1125 clindamycin-resistant Staphylococcus activity observations for AR-0701, AR-0729, and AR-0730.
-
STRUCTURED_ACTIVITY_BIOSAMPLE_ACCESSIONS
Structured BioSample accessions on 3 activity_spectrum observation(s) where evidence notes already named exactly one accession.